Human IFN‑ beta Antibody

Name: Human IFN‑ beta Antibody
Brand: R&D Systems
SKU: 31410-1
Price: 329 USD
Availability: InStock

R&D Systems | Catalog # 31410-1

Submit a review

Citations (2)

Product Documents

100% Guarantee

Product Specifications
Applications
Preparation & Storage
Background
Product Documents
Specific Notices
Research Areas
Related Blogs

Key Product Details

Species Reactivity

Validated:

Human

Cited:

Human

Applications

Validated:

Neutralization

Cited:

Neutralization

Label

Unconjugated

Antibody Source

Polyclonal Rabbit Serum

View all IFN-beta Primary Antibodies »

Product Specifications

Immunogen

E. coli-derived recombinant human IFN-beta

Specificity

Detects Human IFN‑ beta

Clonality

Polyclonal

Host

Rabbit

Isotype

Serum

Applications for Human IFN‑ beta Antibody

Application

Recommended Usage

Neutralization

Optimal dilutions of this antibody should be experimentally determined.

Formulation, Preparation, and Storage

Purification

Antigen Affinity-purified

Formulation

Serum.

Shipping

The product is shipped with dry ice or equivalent. Upon receipt, store it immediately at the temperature recommended below.

Stability & Storage

After receipt, this product should be kept at -70 ˚C or below for retention of full activity. Thaw product vial by incubation in cold tap water until just thawed – the contents of the tube should be apportioned in separate tubes so that freezing and thawing is kept to a minimum. Refreezing should be done on dry ice or in a dry ice/alcohol bath. Further dilution of the product should be in buffers containing protein such as 0.1% bovine serum albumin (BSA).

Background: IFN-beta

Interferon-beta (IFN-beta), along with IFN-alpha and IFN-omega, is a member of the type I interferon family. All three type I interferons share a common cell surface receptor that is composed of two subunits, a 100 kDa ligand-binding subunit (IFN-alpha R2) and a 125 kDa subunit (IFN-alpha R1) that is involved both in ligand binding and signal transduction. Type I interferons were originally described as potent anti-viral molecules produced by virally infected cells.